Geographic location plays a role too
Reports are refreshed annually, with interim updates when material events occur such as major reimbursement shifts, supply disruptions, or label changes, and a final pre delivery pass is completed so the view reflects the latest available information
The FDA officially removed tirzepatide from the shortage list in December 2024 and removed semaglutide in February 2025
The Regulator's Broader Message Beyond the immediate prohibition, CDSCO used the advisory to make a broader public health point: obesity is a chronic metabolic condition that requires comprehensive management, including lifestyle interventions such as diet, exercise, and behavioural change
These programs aren't well advertised but can save hundreds per month
Reference : Related How to Stay Healthy during the festive season